Click for best price
Oncology Drug Discovery Services Market Size, Share 2023
The Oncology Drug Discovery Service is dedicated to oncology research, providing high-quality, timely and cost-effective oncology drug discovery and accelerating the development of the immunooncology product portfolio to develop new drugs that benefit human health.
This report aims to provide a comprehensive presentation of the global market for Oncology Drug Discovery Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Drug Discovery Services. This report contains market size and forecasts of Oncology Drug Discovery Services in global, including the following market information:
Global Oncology Drug Discovery Services Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Oncology Drug Discovery Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Identification Service Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oncology Drug Discovery Services include Charles River, Evotec, GE Healthcare Life Sciences, GenScript, Horizon Discovery, TCG Lifesciences, Zumutor, ChemPartner and Aquila BioMedical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oncology Drug Discovery Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Drug Discovery Services Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Oncology Drug Discovery Services Market Segment Percentages, by Type, 2022 (%)
Identification Service
Authentication Service
Hit-to-lead and Lead Optimization Services
Others
Global Oncology Drug Discovery Services Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Oncology Drug Discovery Services Market Segment Percentages, by Application, 2022 (%)
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
Global Oncology Drug Discovery Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Oncology Drug Discovery Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Drug Discovery Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oncology Drug Discovery Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Charles River
Evotec
GE Healthcare Life Sciences
GenScript
Horizon Discovery
TCG Lifesciences
Zumutor
ChemPartner
Aquila BioMedical
Onconova
Vichem Chemie
GVK Biosciences
NuChem Therapeutics
Syncom
Envigo
DiverChim
Aurora
HD Biosciences
WuXi AppTec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncology Drug Discovery Services, market overview.
Chapter 2: Global Oncology Drug Discovery Services market size in revenue.
Chapter 3: Detailed analysis of Oncology Drug Discovery Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology Drug Discovery Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Oncology Drug Discovery Services Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
101 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oncology Drug Discovery Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Drug Discovery Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Drug Discovery Services Overall Market Size
2.1 Global Oncology Drug Discovery Services Market Size: 2022 VS 2029
2.2 Global Oncology Drug Discovery Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Drug Discovery Services Players in Global Market
3.2 Top Global Oncology Drug Discovery Services Companies Ranked by Revenue
3.3 Global Oncology Drug Discovery Services Revenue by Companies
3.4 Top 3 and Top 5 Oncology Drug Discovery Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncology Drug Discovery Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Drug Discovery Services Players in Global Market
3.6.1 List of Global Tier 1 Oncology Drug Discovery Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Drug Discovery Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncology Drug Discovery Services Market Size Markets, 2022 & 2029
4.1.2 Identification Service
4.1.3 Authentication Service
4.1.4 Hit-to-lead and Lead Optimization Services
4.1.5 Others
4.2 By Type - Global Oncology Drug Discovery Services Revenue & Forecasts
4.2.1 By Type - Global Oncology Drug Discovery Services Revenue, 2018-2023
4.2.2 By Type - Global Oncology Drug Discovery Services Revenue, 2024-2029
4.2.3 By Type - Global Oncology Drug Discovery Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Drug Discovery Services Market Size, 2022 & 2029
5.1.2 Research Institutes
5.1.3 Pharmaceutical Companies
5.1.4 Biotechnology Companies
5.1.5 Others
5.2 By Application - Global Oncology Drug Discovery Services Revenue & Forecasts
5.2.1 By Application - Global Oncology Drug Discovery Services Revenue, 2018-2023
5.2.2 By Application - Global Oncology Drug Discovery Services Revenue, 2024-2029
5.2.3 By Application - Global Oncology Drug Discovery Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Oncology Drug Discovery Services Market Size, 2022 & 2029
6.2 By Region - Global Oncology Drug Discovery Services Revenue & Forecasts
6.2.1 By Region - Global Oncology Drug Discovery Services Revenue, 2018-2023
6.2.2 By Region - Global Oncology Drug Discovery Services Revenue, 2024-2029
6.2.3 By Region - Global Oncology Drug Discovery Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Oncology Drug Discovery Services Revenue, 2018-2029
6.3.2 US Oncology Drug Discovery Services Market Size, 2018-2029
6.3.3 Canada Oncology Drug Discovery Services Market Size, 2018-2029
6.3.4 Mexico Oncology Drug Discovery Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Oncology Drug Discovery Services Revenue, 2018-2029
6.4.2 Germany Oncology Drug Discovery Services Market Size, 2018-2029
6.4.3 France Oncology Drug Discovery Services Market Size, 2018-2029
6.4.4 U.K. Oncology Drug Discovery Services Market Size, 2018-2029
6.4.5 Italy Oncology Drug Discovery Services Market Size, 2018-2029
6.4.6 Russia Oncology Drug Discovery Services Market Size, 2018-2029
6.4.7 Nordic Countries Oncology Drug Discovery Services Market Size, 2018-2029
6.4.8 Benelux Oncology Drug Discovery Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Oncology Drug Discovery Services Revenue, 2018-2029
6.5.2 China Oncology Drug Discovery Services Market Size, 2018-2029
6.5.3 Japan Oncology Drug Discovery Services Market Size, 2018-2029
6.5.4 South Korea Oncology Drug Discovery Services Market Size, 2018-2029
6.5.5 Southeast Asia Oncology Drug Discovery Services Market Size, 2018-2029
6.5.6 India Oncology Drug Discovery Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Oncology Drug Discovery Services Revenue, 2018-2029
6.6.2 Brazil Oncology Drug Discovery Services Market Size, 2018-2029
6.6.3 Argentina Oncology Drug Discovery Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Drug Discovery Services Revenue, 2018-2029
6.7.2 Turkey Oncology Drug Discovery Services Market Size, 2018-2029
6.7.3 Israel Oncology Drug Discovery Services Market Size, 2018-2029
6.7.4 Saudi Arabia Oncology Drug Discovery Services Market Size, 2018-2029
6.7.5 UAE Oncology Drug Discovery Services Market Size, 2018-2029
7 Oncology Drug Discovery Services Companies Profiles
7.1 Charles River
7.1.1 Charles River Company Summary
7.1.2 Charles River Business Overview
7.1.3 Charles River Oncology Drug Discovery Services Major Product Offerings
7.1.4 Charles River Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.1.5 Charles River Key News & Latest Developments
7.2 Evotec
7.2.1 Evotec Company Summary
7.2.2 Evotec Business Overview
7.2.3 Evotec Oncology Drug Discovery Services Major Product Offerings
7.2.4 Evotec Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.2.5 Evotec Key News & Latest Developments
7.3 GE Healthcare Life Sciences
7.3.1 GE Healthcare Life Sciences Company Summary
7.3.2 GE Healthcare Life Sciences Business Overview
7.3.3 GE Healthcare Life Sciences Oncology Drug Discovery Services Major Product Offerings
7.3.4 GE Healthcare Life Sciences Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.3.5 GE Healthcare Life Sciences Key News & Latest Developments
7.4 GenScript
7.4.1 GenScript Company Summary
7.4.2 GenScript Business Overview
7.4.3 GenScript Oncology Drug Discovery Services Major Product Offerings
7.4.4 GenScript Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.4.5 GenScript Key News & Latest Developments
7.5 Horizon Discovery
7.5.1 Horizon Discovery Company Summary
7.5.2 Horizon Discovery Business Overview
7.5.3 Horizon Discovery Oncology Drug Discovery Services Major Product Offerings
7.5.4 Horizon Discovery Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.5.5 Horizon Discovery Key News & Latest Developments
7.6 TCG Lifesciences
7.6.1 TCG Lifesciences Company Summary
7.6.2 TCG Lifesciences Business Overview
7.6.3 TCG Lifesciences Oncology Drug Discovery Services Major Product Offerings
7.6.4 TCG Lifesciences Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.6.5 TCG Lifesciences Key News & Latest Developments
7.7 Zumutor
7.7.1 Zumutor Company Summary
7.7.2 Zumutor Business Overview
7.7.3 Zumutor Oncology Drug Discovery Services Major Product Offerings
7.7.4 Zumutor Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.7.5 Zumutor Key News & Latest Developments
7.8 ChemPartner
7.8.1 ChemPartner Company Summary
7.8.2 ChemPartner Business Overview
7.8.3 ChemPartner Oncology Drug Discovery Services Major Product Offerings
7.8.4 ChemPartner Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.8.5 ChemPartner Key News & Latest Developments
7.9 Aquila BioMedical
7.9.1 Aquila BioMedical Company Summary
7.9.2 Aquila BioMedical Business Overview
7.9.3 Aquila BioMedical Oncology Drug Discovery Services Major Product Offerings
7.9.4 Aquila BioMedical Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.9.5 Aquila BioMedical Key News & Latest Developments
7.10 Onconova
7.10.1 Onconova Company Summary
7.10.2 Onconova Business Overview
7.10.3 Onconova Oncology Drug Discovery Services Major Product Offerings
7.10.4 Onconova Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.10.5 Onconova Key News & Latest Developments
7.11 Vichem Chemie
7.11.1 Vichem Chemie Company Summary
7.11.2 Vichem Chemie Business Overview
7.11.3 Vichem Chemie Oncology Drug Discovery Services Major Product Offerings
7.11.4 Vichem Chemie Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.11.5 Vichem Chemie Key News & Latest Developments
7.12 GVK Biosciences
7.12.1 GVK Biosciences Company Summary
7.12.2 GVK Biosciences Business Overview
7.12.3 GVK Biosciences Oncology Drug Discovery Services Major Product Offerings
7.12.4 GVK Biosciences Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.12.5 GVK Biosciences Key News & Latest Developments
7.13 NuChem Therapeutics
7.13.1 NuChem Therapeutics Company Summary
7.13.2 NuChem Therapeutics Business Overview
7.13.3 NuChem Therapeutics Oncology Drug Discovery Services Major Product Offerings
7.13.4 NuChem Therapeutics Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.13.5 NuChem Therapeutics Key News & Latest Developments
7.14 Syncom
7.14.1 Syncom Company Summary
7.14.2 Syncom Business Overview
7.14.3 Syncom Oncology Drug Discovery Services Major Product Offerings
7.14.4 Syncom Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.14.5 Syncom Key News & Latest Developments
7.15 Envigo
7.15.1 Envigo Company Summary
7.15.2 Envigo Business Overview
7.15.3 Envigo Oncology Drug Discovery Services Major Product Offerings
7.15.4 Envigo Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.15.5 Envigo Key News & Latest Developments
7.16 DiverChim
7.16.1 DiverChim Company Summary
7.16.2 DiverChim Business Overview
7.16.3 DiverChim Oncology Drug Discovery Services Major Product Offerings
7.16.4 DiverChim Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.16.5 DiverChim Key News & Latest Developments
7.17 Aurora
7.17.1 Aurora Company Summary
7.17.2 Aurora Business Overview
7.17.3 Aurora Oncology Drug Discovery Services Major Product Offerings
7.17.4 Aurora Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.17.5 Aurora Key News & Latest Developments
7.18 HD Biosciences
7.18.1 HD Biosciences Company Summary
7.18.2 HD Biosciences Business Overview
7.18.3 HD Biosciences Oncology Drug Discovery Services Major Product Offerings
7.18.4 HD Biosciences Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.18.5 HD Biosciences Key News & Latest Developments
7.19 WuXi AppTec
7.19.1 WuXi AppTec Company Summary
7.19.2 WuXi AppTec Business Overview
7.19.3 WuXi AppTec Oncology Drug Discovery Services Major Product Offerings
7.19.4 WuXi AppTec Oncology Drug Discovery Services Revenue in Global Market (2018-2023)
7.19.5 WuXi AppTec Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oncology Drug Discovery Services Market Opportunities & Trends in Global Market
Table 2. Oncology Drug Discovery Services Market Drivers in Global Market
Table 3. Oncology Drug Discovery Services Market Restraints in Global Market
Table 4. Key Players of Oncology Drug Discovery Services in Global Market
Table 5. Top Oncology Drug Discovery Services Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oncology Drug Discovery Services Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oncology Drug Discovery Services Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oncology Drug Discovery Services Product Type
Table 9. List of Global Tier 1 Oncology Drug Discovery Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Drug Discovery Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oncology Drug Discovery Services Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Oncology Drug Discovery Services Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oncology Drug Discovery Services Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Oncology Drug Discovery Services Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Oncology Drug Discovery Services Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oncology Drug Discovery Services Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Oncology Drug Discovery Services Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Oncology Drug Discovery Services Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oncology Drug Discovery Services Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oncology Drug Discovery Services Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oncology Drug Discovery Services Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oncology Drug Discovery Services Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oncology Drug Discovery Services Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oncology Drug Discovery Services Revenue, (US$, Mn), 2024-2029
Table 30. Charles River Company Summary
Table 31. Charles River Oncology Drug Discovery Services Product Offerings
Table 32. Charles River Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 33. Charles River Key News & Latest Developments
Table 34. Evotec Company Summary
Table 35. Evotec Oncology Drug Discovery Services Product Offerings
Table 36. Evotec Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 37. Evotec Key News & Latest Developments
Table 38. GE Healthcare Life Sciences Company Summary
Table 39. GE Healthcare Life Sciences Oncology Drug Discovery Services Product Offerings
Table 40. GE Healthcare Life Sciences Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 41. GE Healthcare Life Sciences Key News & Latest Developments
Table 42. GenScript Company Summary
Table 43. GenScript Oncology Drug Discovery Services Product Offerings
Table 44. GenScript Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 45. GenScript Key News & Latest Developments
Table 46. Horizon Discovery Company Summary
Table 47. Horizon Discovery Oncology Drug Discovery Services Product Offerings
Table 48. Horizon Discovery Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 49. Horizon Discovery Key News & Latest Developments
Table 50. TCG Lifesciences Company Summary
Table 51. TCG Lifesciences Oncology Drug Discovery Services Product Offerings
Table 52. TCG Lifesciences Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 53. TCG Lifesciences Key News & Latest Developments
Table 54. Zumutor Company Summary
Table 55. Zumutor Oncology Drug Discovery Services Product Offerings
Table 56. Zumutor Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 57. Zumutor Key News & Latest Developments
Table 58. ChemPartner Company Summary
Table 59. ChemPartner Oncology Drug Discovery Services Product Offerings
Table 60. ChemPartner Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 61. ChemPartner Key News & Latest Developments
Table 62. Aquila BioMedical Company Summary
Table 63. Aquila BioMedical Oncology Drug Discovery Services Product Offerings
Table 64. Aquila BioMedical Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 65. Aquila BioMedical Key News & Latest Developments
Table 66. Onconova Company Summary
Table 67. Onconova Oncology Drug Discovery Services Product Offerings
Table 68. Onconova Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 69. Onconova Key News & Latest Developments
Table 70. Vichem Chemie Company Summary
Table 71. Vichem Chemie Oncology Drug Discovery Services Product Offerings
Table 72. Vichem Chemie Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 73. Vichem Chemie Key News & Latest Developments
Table 74. GVK Biosciences Company Summary
Table 75. GVK Biosciences Oncology Drug Discovery Services Product Offerings
Table 76. GVK Biosciences Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 77. GVK Biosciences Key News & Latest Developments
Table 78. NuChem Therapeutics Company Summary
Table 79. NuChem Therapeutics Oncology Drug Discovery Services Product Offerings
Table 80. NuChem Therapeutics Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 81. NuChem Therapeutics Key News & Latest Developments
Table 82. Syncom Company Summary
Table 83. Syncom Oncology Drug Discovery Services Product Offerings
Table 84. Syncom Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 85. Syncom Key News & Latest Developments
Table 86. Envigo Company Summary
Table 87. Envigo Oncology Drug Discovery Services Product Offerings
Table 88. Envigo Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 89. Envigo Key News & Latest Developments
Table 90. DiverChim Company Summary
Table 91. DiverChim Oncology Drug Discovery Services Product Offerings
Table 92. DiverChim Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 93. DiverChim Key News & Latest Developments
Table 94. Aurora Company Summary
Table 95. Aurora Oncology Drug Discovery Services Product Offerings
Table 96. Aurora Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 97. Aurora Key News & Latest Developments
Table 98. HD Biosciences Company Summary
Table 99. HD Biosciences Oncology Drug Discovery Services Product Offerings
Table 100. HD Biosciences Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 101. HD Biosciences Key News & Latest Developments
Table 102. WuXi AppTec Company Summary
Table 103. WuXi AppTec Oncology Drug Discovery Services Product Offerings
Table 104. WuXi AppTec Oncology Drug Discovery Services Revenue (US$, Mn) & (2018-2023)
Table 105. WuXi AppTec Key News & Latest Developments
List of Figures
Figure 1. Oncology Drug Discovery Services Segment by Type in 2022
Figure 2. Oncology Drug Discovery Services Segment by Application in 2022
Figure 3. Global Oncology Drug Discovery Services Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oncology Drug Discovery Services Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oncology Drug Discovery Services Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncology Drug Discovery Services Revenue in 2022
Figure 8. By Type - Global Oncology Drug Discovery Services Revenue Market Share, 2018-2029
Figure 9. By Application - Global Oncology Drug Discovery Services Revenue Market Share, 2018-2029
Figure 10. By Type - Global Oncology Drug Discovery Services Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Oncology Drug Discovery Services Revenue Market Share, 2018-2029
Figure 12. By Application - Global Oncology Drug Discovery Services Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Oncology Drug Discovery Services Revenue Market Share, 2018-2029
Figure 14. By Region - Global Oncology Drug Discovery Services Revenue Market Share, 2018-2029
Figure 15. By Country - North America Oncology Drug Discovery Services Revenue Market Share, 2018-2029
Figure 16. US Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Oncology Drug Discovery Services Revenue Market Share, 2018-2029
Figure 20. Germany Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 21. France Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Oncology Drug Discovery Services Revenue Market Share, 2018-2029
Figure 28. China Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 32. India Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Oncology Drug Discovery Services Revenue Market Share, 2018-2029
Figure 34. Brazil Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Oncology Drug Discovery Services Revenue Market Share, 2018-2029
Figure 37. Turkey Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Oncology Drug Discovery Services Revenue, (US$, Mn), 2018-2029
Figure 41. Charles River Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Evotec Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GE Healthcare Life Sciences Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GenScript Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Horizon Discovery Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. TCG Lifesciences Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Zumutor Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. ChemPartner Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Aquila BioMedical Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Onconova Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Vichem Chemie Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. GVK Biosciences Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. NuChem Therapeutics Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Syncom Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Envigo Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. DiverChim Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Aurora Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. HD Biosciences Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. WuXi AppTec Oncology Drug Discovery Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
